DiBiase Mary - Insider Transactions
Insider Type
individual
Companies
1
Average
19,480
Total Txns
6
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 1 | -1 | 0.00 | 49,417.35 | -49,417.35 |
| 2024 | 0 | 4 | -4 | 0.00 | 57,366.07 | -57,366.07 |
| 2025 | 0 | 1 | -1 | 0.00 | 10,094.00 | -10,094.00 |
| Total: | 0 | 6 | 6 | 0.00 | 116,877.42 | -116,877.42 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. Common Stock US98420X1037 |
0.45 USD |
22,258 Sold |
10,094 USD |
23/01/2025 | 24/01/2025 |
| X4 Pharmaceuticals, Inc. Common Stock US98420X1037 |
0.57 USD |
67,695 Sold |
38,329 USD |
04/10/2024 | 07/10/2024 |
| X4 Pharmaceuticals, Inc. Common Stock US98420X1037 |
0.66 USD |
2,642 Sold |
1,738 USD |
09/09/2024 | 09/09/2024 |
| X4 Pharmaceuticals, Inc. Common Stock US98420X1037 |
0.88 USD |
15,409 Sold |
13,591 USD |
11/03/2024 | 11/03/2024 |
| X4 Pharmaceuticals, Inc. Common Stock US98420X1037 |
1.01 USD |
3,683 Sold |
3,709 USD |
12/02/2024 | 12/02/2024 |
| X4 Pharmaceuticals, Inc. Common Stock US98420X1037 |
0.73 USD |
67,695 Sold |
49,417 USD |
01/11/2023 | 01/11/2023 |